D-Index & Metrics Best Publications

Mark H. Greene

National Institutes of Health
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 87 Citations 25,920 296 World Ranking 8815 National Ranking 4684

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What are the main themes of his work throughout his whole career to date

Mark H. Greene performs multidisciplinary study in the fields of Gene and Transcriptome via his papers. In his research, he performs multidisciplinary study on Transcriptome and Gene expression. Mark H. Greene integrates Gene expression and Bioinformatics in his research. He performs multidisciplinary study in the fields of Bioinformatics and Single-nucleotide polymorphism via his papers. Mark H. Greene undertakes interdisciplinary study in the fields of Single-nucleotide polymorphism and Genome-wide association study through his research. In his articles, he combines various disciplines, including Genome-wide association study and Linkage disequilibrium. His work blends Linkage disequilibrium and Allele studies together. He merges Allele with Haplotype in his research. He merges Haplotype with Genetic association in his research.

Mark H. Greene most often published in these fields:

Gene (85.71%)
Genetics (85.71%)
Single-nucleotide polymorphism (71.43%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma

Wallace H. Clark;David E. Elder;Dupont Guerry;Martin N. Epstein.
Human Pathology (1984)

1239 Citations

Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.

Wallace H. Clark;Ronald R. Reimer;Mark Greene;Ann M. Ainsworth.
Archives of Dermatology (1978)

1046 Citations

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)

616 Citations

Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki.
JAMA (2012)

612 Citations

Cancer incidence in persons with Fanconi anemia.

Philip S. Rosenberg;Mark H. Greene;Blanche P. Alter.
Blood (2003)

607 Citations

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)

604 Citations

High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi

Mark H. Greene;Wallace H. Clark;Margaret A. Tucker;Kenneth H. Kraemer.
Annals of Internal Medicine (1985)

571 Citations

Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma

David E. Elder;Leonard I. Goldman;Susan C. Goldman;Mark H. Greene.
Cancer (1980)

570 Citations

Detectable clonal mosaicism and its relationship to aging and cancer

Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder.
Nature Genetics (2012)

564 Citations

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p

Sherri J. Bale;Nicholas C. Dracopoli;Margaret A. Tucker;Wallace H. Clark.
The New England Journal of Medicine (1989)

430 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Mark H. Greene